John Amuasi (EXECUTIVE DIRECTOR)
About John Amuasi (EXECUTIVE DIRECTOR)
Kumasi Center for Collaborative Research In Trop. Med.Tel: +233 3220 60351 (Ext. 124) | Email: firstname.lastname@example.org
Dr. Amuasi leads the Secretariat of the African Research Network for Neglected Tropical Diseases (ARNTD) as Executive Director. He is a senior lecturer at the Kwame Nkrumah University of Science and Technology (KNUST), where he is head of the Global Health Department of the School of Public Health. Dr. Amuasi is also Group Leader of the Global Health and Infectious Diseases Research Group at the Kumasi Center for Collaborative Research in Tropical Medicine (KCCR). Dr. Amuasi trained as a physician at KNUST and later graduated from the University of Minnesota School of Public Health, USA, with post-graduate degrees terminating in a PhD in Health Research and Policy. He also served as head of the R&D Unit at the 1,200-bed Komfo Anokye teaching Hospital in Kumasi, Ghana for 3 years from 2007-2010. Dr. Amuasi has consulted for several international organizations and is passionate about research that focuses on improving health systems, services and outcomes, including policy analyses using both primary and secondary data in low and middle-income countries. His research currently involves field epidemiologic studies on malaria, snakebite and other neglected tropical diseases. Dr. Amuasi serves as an Executive Committee member of the African Coalition for Epidemic Research, Response and Training (ALERRT). Through ALERRT at KCCR, Dr. Amuasi is coordinating research on the clinical characterization of COVID-19 in Africa and is the PI for a number of studies on COVID-19 in Ghana, including some phase III clinical trials. Dr. Amuasi serves as a technical advisor to a number of academic institutions, governments and global health bodies, including the WHO, Africa CDC, IPBES and the World Bank on a wide range of global health subjects. Dr. Amuasi also co-chairs the Lancet One Health Commission and is at the forefront of global efforts towards addressing emerging and re-emerging infectious diseases using a One Health approach.